Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

HEALTH LITERACY: Understanding osteoporosis: Causes, risk factors, and preventive strategies for bone health ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Why are postmenopausal women more susceptible to bone issues? “Bone density peaks at around 35 years old then naturally decreases with age,” explains Dr Thom Phillips, NHS GP and clinical lead at ...

Supplementation with cholecalciferol 1000 IU/day during pregnancy is associated with greater offspring bone mineral density during childhood.

Patients with cystic fibrosis (CF) experience significant bone mineral density (BMD) loss at a younger age than those without the disease, with greater decline observed among individuals with ...

Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy.

Research indicates that vitamin D supplementation during pregnancy positively impacts children's bone health and lean mass, ...

Shares of Amgen fell as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss ...

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...